Background: Due to the high mortality rate, the therapy of patients (PTS) with an acute coronary syndrome (ACS) and cardiogenic shock (CS) remains still a challenge. Over many years we… Click to show full abstract
Background: Due to the high mortality rate, the therapy of patients (PTS) with an acute coronary syndrome (ACS) and cardiogenic shock (CS) remains still a challenge. Over many years we used an intra-aortic balloon pump (IABP), but with disappointing results. After the publication of the SHOCK II
               
Click one of the above tabs to view related content.